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Abstract
In recent years, multidrug resistance of Shigella strains associated with genetic elements
like pathogenicity islands, have become a public health problem. The Shigella resistance
locus pathogenicity island (SRL PAI) of S. flexneri 2a harbors a 16Kbp region that contrib-
utes to the multidrug resistance phenotype. However, there is not much information about
other functions such as metabolic, physiologic or ecological ones. For that, wild type S. flex-
neri YSH6000 strain, and its spontaneous SRL PAI mutant, 1363, were used to study the
contribution of the island in different growth conditions. Interestingly, when both strains were
compared by the Phenotype Microarrays, the ability to metabolize D-aspartic acid as a car-
bon source was detected in the wild type strain but not in the mutant. When D-aspartate was
added to minimal medium with other carbon sources such as mannose or mannitol, the SRL
PAI-positive strain was able to metabolize it, while the SRL PAI-negative strain did not. In
order to identify the genetic elements responsible for this phenotype, a bioinformatic analy-
sis was performed and two genes belonging to SRL PAI were found: orf8, coding for a puta-
tive aspartate racemase, and orf9, coding for a transporter. Thus, it was possible to
measure, by an indirect analysis of racemization activity in minimal medium supplemented
only with D-aspartate, that YSH6000 strain was able to transform the D-form into L-, while
the mutant was impaired to do it. When the orf8-orf9 region from SRL island was trans-
formed into S. flexneri and S. sonnei SRL PAI-negative strains, the phenotype was restored.
Although, when single genes were cloned into plasmids, no complementation was
observed. Our results strongly suggest that the aspartate racemase and the transporter
encoded in the SRL pathogenicity island are important for bacterial survival in environments
rich in D-aspartate.







Citation: Henrı´quez T, Salazar JC, Marvasi M, Shah
A, Corsini G, Toro CS (2020) SRL pathogenicity
island contributes to the metabolism of D-aspartate
via an aspartate racemase in Shigella flexneri
YSH6000. PLoS ONE 15(1): e0228178. https://doi.
org/10.1371/journal.pone.0228178
Editor: Riccardo Manganelli, University of Padova,
Medical School, ITALY
Received: September 16, 2019
Accepted: January 8, 2020
Published: January 24, 2020
Copyright: © 2020 Henrı´quez et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files.
Funding: This work was supported by FONDECYT
grant 1130394 to CT and CONICYT Doctoral
Scholarship 2012-2016, Uch1304 MECESUP
Fellowship for doctoral internship 2015 and
Operational expenses for Doctoral thesis, CONICYT
(Res. 8994), 2014 to TH. HPLC and MS-LS were
funded through Research Funds from MM and AS,
Middlesex University London. Publication fees are
Introduction
Shigella spp. is the causative agent of shigellosis, a worldwide disease common in children
under the age of five [1–3]. In recent years, multidrug resistance (MDR) of several Shigella
strains has become a public health problem [4, 5]. Among genetic elements associated to
MDR, resistance genes harbored in the SRL pathogenicity island (SRL PAI) were identified as
contributors to the resistance phenotype [6]. SRL PAI is a 66 kbp element that contains a 16
kbp SRL region (Shigella Resistance Locus), which codifies resistance to streptomycin
(aadA1), ampicillin (oxa-1), chloramphenicol (cat) and tetracycline (tetB) genes [6–8]. Few
genes inside the SRL island have been characterized beside the resistance genes: int, rox, and
fec genes encoding for the ferric dicitrate transport system (Fec) [6, 7]. The Fec system seems
important in ferric metabolism, however it is not essential during bacterial growth under iron
limited conditions (probably due to the presence of other iron carriers) [6].
However, when different SRL PAI features have been searched, not much information is
available and the role of this island in Shigella survival and replication inside or outside the
host is not known. The primary host and natural reservoir known for Shigella spp. is the
human gastrointestinal tract; however, it can survive in different environments: S. flexneri sur-
vival has been detected in 0.9% NaCl solution and distilled water at about 5˚C for 87 and 83
days, respectively [9], and S. sonnei can survive on the surface of a lettuce for 3 days at 5˚C
[10]. Some studies indicate that Shigella spp. is capable of surviving in conditions that could be
considered extreme for other enterobacteria, for example, growth at pH 2.5 [11]. This resis-
tance can be related to the extreme environmental condition that bacteria could face in order
to survive and multiply inside and outside the host. In particular, the resistance to acidic pH
would be akin to passing through the human stomach (pH<3). Other important feature of Shi-
gella is that it can survive within macrophages [12]. Though, to date, the mechanisms and
genes involved to cope with these conditions have not been described.
Recently, our attention has been focused on analyzing other functions of the SRL PAI
beyond antibiotic resistance. Altogether, 59 open reading frames (ORF) were identified within
the SRL PAI, most of them are only putative [6]. Interestingly, the comparison of the SRL PAI
positive-strain, YSH6000, and its isogenic mutant, 1363, showed a difference in the ability to
metabolize D-aspartate (D-Asp). When protein similarity was inferred into S. flexneri SRL
PAI, a putative aspartate racemase was identified, followed by a transporter associated with the
aspartic acid metabolism (orf8 and orf9, respectively). The activity of these genes and their role
in adverse conditions of growth, such as in presence of high concentration of D-Asp, were fur-
ther investigated.
Materials and methods
Bacterial strains and culture media
Shigella flexneri 2a YSH6000 and S. flexneri 2a 1363 (with a spontaneous deletion of the SRL
PAI) [6] were kindly provided by Dr. Ben Adler. Shigella sonnei 566 wild type strain without
the SRL PAI was used as a control. A complete list of strains and plasmids used in this study is
available in S1 Table. All the strains were cultured in Lysogeny Broth (LB) medium and main-
tained as a frozen glycerol stock.
When D-Asp was used, Shigella was grown in minimal medium containing 1X Minimal
Salt (Invitrogen, Carlsbad, US) with 2 mM MgSO4, 45 μM methionine, 12.5 μM nicotinic acid
and 30 mM D-Asp (all reagents are from Sigma-Aldrich, St. Louis, US). Recombinant strains
were grown in the presence of gentamicin (10 μg mL-1), when appropriate. For growth experi-
ments using recombinant strains, optimized minimal medium containing M9 salts 1X, MgSO4
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(2mM), CaCl2 (0.1mM), trace elements (134 μM EDTA, 31 μM FeCl3, 6.2 μM ZnCl2, 0.76 μM
CuCl2, 0.42 μMCoCl2, 1.62 μM H3Bo3, 81 nM MnCl2), biotin (1 μg mL-1), thiamine (30 μM),
methionine (10 μg mL-1), cysteine (10 μg mL-1), nicotinic acid (10 μg mL-1), tryptophan (20 μg
mL-1), gentamicin (2 μg mL-1), IPTG (0.5 mM) and L- or D- aspartic acid (25 mM) was used.
Complementation of the orf8-orf9 region and of each single gene in SRL
PAI negative strains
Gentamicin was used as an additional selector marker since the SRL PAI already confers resis-
tance to ampicillin, streptomycin, tetracycline and chloramphenicol. Therefore, pUC18 was
modified with a gentamicin resistance (GR) cassette to select recombinant strains. To that end,
GR cassette from strain TP997 (Addgene, Cambridge, Massachusetts, USA) was amplified
using primers: P1-5’CGAATCCATGTGGGAGTTTA3’; P2-5’TTAGGTGGCGGTACTTGG
GT3’, as described by Poteete et al. [13]. Then, GR cassette was cloned into pUC18 using the
restriction enzyme SspI (NEB, Ipswich, USA) and ligated with T4 ligase (Invitrogen, Carlsbad,
US) producing plasmid pUC18G. Secondly, region orf8-orf9 (including the putative promoter
of orf8, identified by BPROM software) was amplified from S. flexneri YSH6000 using primers
Fw 5’CCGGAATTCAAGCGGAATGTTCCATAGCTG3’ and Rev 5’CGCGGATCCGGTATCA
AAAAGCGATAGATGCAG3’ and KAPA HiFi enzyme (Kapa Biosystems). Then, it was cloned
into the polylinker site of pUC18G after its digestion with SmaI. The resulting pUC18G
orf8-orf9 and pUC18G (empty vector) were electroporated into S. flexneri 1363 and S. sonnei
566 strains, producing complemented strains (1363 pUC18G orf8-orf9 and 566 pUC18G
orf8-orf9), and control strains with the empty plasmid (1363 pUC18G and 566 pUC18G)
respectively. Cloning of single genes was achieve by using pUC18G as template for PCR using
the primers pUC18F (5’-AGCTGTTTCCTGTGTGAAA-3’) and pUC18 Hind (5’-GGCATG
CAAGCTTGGCACT-3’). With these primers, the modified pUC18 was amplified without the
ATG of the lacZ gene, allowing the cloning of the orf8 or orf9 under the control of the tac pro-
moter. In parallel, orf8 was amplified from YSH6000 using the primers Fw 5’-ATGGGGCCG
GCAGCTAC-3 and Rev 5’-GCGAATAAGCTTCTGGCTGCG-3’, while orf9 was amplified
using Fw 5’-ATGGTTTGGCTGGAAATT-3’ and Rev 5’-ATGTAAGCTTGTGCTAAATA-
3’. Then, the vector and insert were digested with HindIII (NEB) and ligated using T4 DNA
ligase (NEB) according to manufacturer´s instructions. The resulting plasmids pUC18G orf8
and pUC18G orf9 were then electroporated into S. flexneri 1363. As an additional control for
optimized minimal medium, YSH6000 was electroporated with pUC18G (empty vector).
Biochemical characterization
S. flexneri YSH6000 and S. flexneri 1363 were phenotypically characterized by microbial identi-
fication system of VITEK 2 compact (Biomerieux) according to manufacturers’ instructions.
For this purpose, Gram Negative (GN) card was used. Further biochemical characterization
was performed using Biolog (Biolog, Hayward, California, USA) through Phenotype Microar-
ray (PM) assay [14] using panels one to eight. PM Biolog technology allowed us to analyze
~750 cellular phenotypes (including C, N, P, and S metabolism pathways). Each strain was
tested in duplicate. Succinate was used as carbon sources for Biolog PM panels three to eight
as per user’s manual recommendations. Nicotinic acid was used to cover auxotrophic require-
ment in plates PM one to PM eight. The redox chemistry used in PM Biolog employs cell respi-
ration by reducing a tetrazolium dye leading to a color change. The plates were incubated at
37˚C and change of color of the tetrazolium dye was measured every 15 min for 48 h.
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Bioinformatics analysis
S. flexneri YSH6000 SRL PAI was analyzed using the GenBank sequence previously deposited
in 2001 (accession number AF326777.3) [6]. Nucleotide and Protein BLASTs were used to
analyze putative ORFs. The analysis of putative promoters was performed using BPROM (Soft-
berry) tool.
Triphenyl tetrazolium chloride (TTC) reduction in presence of D-aspartic
acid and mannose or mannitol as carbon source
To measure respiration of the bacteria in presence of D-Asp (metabolic activity), 1 mL of over-
night LB culture of all strains was collected (15 000 rcf for 3 minutes) and washed three times
with Phosphate Saline Buffer (PBS) 1X to remove medium residuals. Subsequently, pellets
were suspended in 1 mL of D-Asp Minimal Medium containing 1X Minimal Salt (Invitrogen,
Carlsbad, US) with 2 mM MgSO4, 45 μM methionine, 12.5 μM nicotinic acid and 0.01% tri-
phenyl tetrazolium chloride (TTC). When needed, D-Asp was used at 0.01%. 40 mM mannose
or 40 mM mannitol were used as carbon source. Suspensions were normalized using a Thermo
Scientific, Helios Epsilon model, spectrophotometer and cultures were incubated for 24 h at
37˚C and 115 rpm. After the incubation, 1 ml of cells was centrifuged (3 minutes at 15 000 rcf)
and the supernatant was used to measure TTC reduction (reflecting respiration). Final absor-
bance (using a spectrophotometer set at 490 nm [15]) minus initial absorbance was calculated.
Quantification of D- and L-aspartic acid using HPLC/MS-MS
1 mL of each overnight cultures in LB was washed three times with PBS and then suspended in
Minimal Medium containing 30 mg mL-1 of D-Asp. Suspensions were incubated in a shaker
for 24 h at 37˚C and 115 rpm. After incubation, suspensions were filtered using a 0.20 μm
polyvinylidene difluoride syringe filters (Fisher Scientific), and then stored at -80˚C for liquid
chromatography–mass spectrometry/mass spectrometry (LC-MS/MS) analysis. A Jasco
(Chelmsford, UK) HPLC system composed of two X-LC 3085 PU pumps, a X-LC 3080DG
degasser, a X-LC 3190MX mixer, a CO-2067 intelligent column oven set at 25˚C and a Waters
2777 (Elstree, UK) sample manager set at 4˚C. Separation was performed using a mixture of
water and methanol (30:70, v/v) containing 0.1% formic acid at a flow rate of 0.21 mL min-1
and a 250 x 2.0 mm I.D. Chirobiotic Tag 5 μm chiral column (Sigma Aldrich, Poole, UK). The
separated analytes were detected using an API3000 triple quadrupole mass spectrometer
(Sciex, Warrington, UK) equipped with an electrospray interface and operated in positive ion
mode. The molecular reaction monitoring (MRM) transitions used for detection of aspartate
were m/z 133.96! 74 and 133.96! 88 with unit resolution. The delay time was set to 200
msec. The optimum declustering, focusing and entrance potential were found to be 34, 90 and
10 V respectively. The collision energy, collision cell exit potential, ion spray voltage and
source temperature were set at 21 V, 13 V, 5000 V and 300˚C respectively. In minimal
medium, the peak for L-Asp was observed at 5.32 min and for D-Asp at 7.81 min.
Quantification of bacterial growth
For the measurement of growth after overnight incubation (16h), optimized minimal medium
with D-Asp was used. To that end, each strain transformed with a plasmid was grown in LB
plus gentamicin (10 μg mL-1) until an OD ~1.8, centrifuged (3 minutes at 15 000 rcf), washed
three times with PBS 1X, and then used to start a new culture with an OD ~0.2. After 16 hours
of incubation at 37˚C with continuous shaking (140 rpm), OD600 was measured and final OD
minus initial OD was calculated.
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For growth curves, cells were prepared in the same way described above and used to inocu-
late minimal medium with D-Asp or L-Asp. Incubation was performed at 37˚C with continu-
ous shaking (140 rpm). Each hour, 0.5 ml of culture was taken and measured at 600 nm.
Statistical analysis
The statistical software JMP (SAS) package and Prism 8 were used to infer the one-way
ANOVA analysis (p<0.05) and T-test. Tukey means separation analysis was performed in
order to group the means.
Results
SRL PAI allows S. flexneri YSH6000 strain to metabolize D-aspartic acid
In order to identify the contribution of the SRL pathogenicity island (SRL PAI) to main meta-
bolic routes, S. flexneri 2a YSH6000 and its isogenic mutant, S. flexneri 2a 1363 (spontaneous
excision of the SRL PAI) were inoculated in Vitek 2 Compact GN cards. No differences were
observed when 47 biochemical tests were used (S2 Table). A further comparison was per-
formed through Phenotype MicroArrays (PMs) by carrying out a functional phenotypic
screening of about 800 metabolites. Interestingly, the major difference observed in the screen-
ing indicated that the SLR PAI-negative strain, S. flexneri 2a 1363, lost the ability to metabolize
the D-Asp (Table 1). PM analysis results did not show significant differences in the metabo-
lism of other D-amino acids between both strains, suggesting a specific effect. This strain also
gained the capability to metabolize D-raffinose (S3 Table). Since the ability to metabolize D-
amino acids seems to be important for bacterial survival in the environment [16], respiration
in presence of D-Asp was selected for further characterization.
D- amino acids might have a great impact on bacterial communities. Thus, the presence of
D- amino acids have been reported to influence physiological processes such as biofilm forma-
tion, sporulation and peptidoglycan remodeling [17–18].
On the other hand, D- amino acids toxicity has also been reported, such as a pioneering
study by Eisenstadt and coworkers which showed the detrimental effect of D-Asp on bacterial
growth [19–20]. To determine whether SRL PAI has positive impact over bacteria growing in
the presence of D-Asp, we measured metabolic activity of strains by using other carbon
sources plus D-Asp. We selected mannose and mannitol, two sugars that were previously iden-
tified by Vitek 2 Compact as preferred carbon sources for growth. When 0.01% D-Asp was
added, S. flexneri YSH6000 had a higher respiration rate (measured with the redox indicator
TTC) in mannose minimal medium compared to the media without D-Asp. On the contrary,
S. flexneri 1363 strain had a significant decrease in growth in mannose minimal medium when
it was supplemented with D-Asp (Fig 1A). Similar findings were obtained in presence of man-
nitol for YSH6000 strain (Fig 1B), suggesting the toxicity of the D- form in such growth condi-
tions and the role of SRL PAI for detoxification.
Table 1. Phenotype microarray comparison between S. flexneri 2a 1363 against S. flexneri 2a YSH6000.
Difference in respiration� Test Phenotype Mode of action
54 D-raffinose Gained C-Source; carbohydrate
-109 D-aspartic acid Lost C-Source; amino acid
� The value represents a comparison of the difference in the average height of the respiration curve of S. flexneri 2a 1363 versus S. flexneri YSH6000
https://doi.org/10.1371/journal.pone.0228178.t001
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A putative aspartate racemase is coded by orf8
Bioinformatics analysis of the 59 ORF harbored in SRL PAI was performed (Table 2). A previ-
ous bioinformatics analysis was conducted by Luck and coworkers [6] (Table 2, left side), how-
ever an updated analysis of each ORF showed significant modifications due to the updated
information available in recent data repository (NCBI). Forty percent of the proteins were re-
assigned with significant differences (Table 2). From our analysis, orf8 product was selected as
the most probable contributor to the phenotype associated to D-Asp as an aspartate racemase
(Table 2). Interestingly orf9, has been identified as an anaerobic C4-dicarboxylate membrane
transporter protein DcuA (100% identity, Table 2) and it also could be associated with D/L-
aspartate translocation through the cell. Therefore, we selected orf8-orf9 region from the SRL
PAI (S1 Fig) as the probable genes responsible for the observed phenotype. In parallel, the role
of the island in the metabolism of other phenotypes identified by PMs, such as D-raffinose,
was assessed, however, no evident connection between them was found. It is possible that
these phenotypes are related to the interaction of the SRL island with metabolic routes encoded
by other sequences in the genome. Further studies are needed in order to determine their
molecular cause.
To assess the role of the putative aspartate racemase and the DcuA protein in bacterial res-
piration in presence of D-Asp, the orf8-orf9 region including its putative promoter upstream
of orf8, was cloned within the pUC18G vector, originating pUC18G orf8-orf9. Negative strains
for the SRL PAI, S. flexneri 2a 1363 and S. sonnei 566, were independently transformed with
the recombinant plasmid and with pUC18G empty vector (as control). S. sonnei was used as
an additional negative control, being a related phylogenetic strain not harboring the SRL PAI.
The phenotypes were analyzed by culturing Shigella strains in minimal medium with D-Asp as
Fig 1. Effect of D-aspartic acid on bacterial metabolism in presence of mannose or mannitol as carbon source. Reference strains were grown in
Shigella Minimal Medium with mannose (A) or mannitol (B) as carbon source supplemented with D-Asp at 0.01% w/v. Bars show the change on redox
indicator (TTC) at 24 h of incubation (final absorbance minus initial absorbance). T-test was performed and significant results are represented by
asterisks (� = p<0.05). Error bars represent standard deviation.
https://doi.org/10.1371/journal.pone.0228178.g001
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a sole carbon source and 0.01% TTC as a redox indicator. Using these conditions, S. flexneri 2a
YSH6000 was able to metabolize D-Asp to a significantly higher extent than S. flexneri 1363, in
accordance to the results from the Phenotype MicroArrays (Fig 2A). Moreover, negative SRL
Table 2. Update of the probable products of the ORFs contained in the SRL PAI.
ORF1 Gene Related protein (Luck et al., 2001) % Similarity# Related protein (This work) % Similarity#
2 orf2 Yfjl 45 Hypothetical protein (DUF 3987) 100�
4 orf4 No similarity - Hypothetical protein 100�
5 orf5 No similarity - Inovirus Gp2 family protein 100�
6 orf6 Yfjl (frameshift) 73 Inovirus Gp2 family protein 100
7 orf7 LysR-like transcriptional regulator 79 LysR-like transcriptional regulator 100
8 orf8 Hypothetical protein in LysR-AraE 63 Aspartate racemase 99.56
9 orf9 DcuA (anaerobic decarboxylate transporter) 70 DcuA (anaerobic decarboxylate transporter) 100�
17 orf17 YdjB 79 Amino acid-binding protein 100 �
18 orf18 JemC 79 ArsR family transcriptional regulator 95.88
23 orf23 CapU (hexosyltransferase homolog) 99, 73 Glycosyl transferase family 1 100 �
24 orf24 Shf 93, 92.3 Putative protein shf 100+
25 orf25 Hypothetical ORF o137 98 Hypothetical protein 100
34 orf34 Putative periplasmic protein (Campylobacter jejuni) 52 Esterase-like activity of phytase family protein 99.78
35 orf35 L0015 98 IS66 family transposase 99.57
36 orf36 L0014 98 IS66 family insertion sequence element accessory protein TnpB 100�
37 orf37 L0013 99 Transposase 99.25
38 orf38 No similarity - Hypothetical protein 100�
39 orf39 YfjJ 55 Inovirus Gp2 family protein 100�
40 orf40 Hha/YmoA (Yersinia enterocolitica) 75, 75 Hemolysin activation protein 100
41 orf41 Vis (P4) 53 AlpA family transcriptional regulator 100�
42 orf42 No similarity - Hypothetical protein 100�
43 orf43 No similarity - Uncharacterized protein 75.52
44 orf44 No similarity - Hypothetical protein 100�
45 orf45 No similarity - Hypothetical protein 100�
46 orf46 YfjP, YeeP 65, 97 50S ribosome-binding GTPase 99.66
47 orf47 Ag43 (Flu) 78 autotransporter adhesin Ag43 99.47+
48 orf48 YfjQ 88 DUF945 domain-containing protein, partial 98.86
49 orf49 YfjX, KlcA 81, 51 Hypothetical protein SFxv_1159 93.33 +
50 orf50 YfjY, YeeS 80, 99 Putative radC-like protein yeeS 98.77
51 orf51 YeeT 98 DNA repair RadC family protein, partial 100
52 orf52 YeeU, YfjZ 91, 75 type IV toxin-antitoxin system YeeU family antitoxin 97.58�
53 orf53 L0007, YeeV, YpjJ 93, 87, 74 Toxin 100 �
54 orf54 L0008, YeeW 96, 77 hypothetical protein 99.39�
55 orf55 L0009 88 DUF957 domain-containing protein 100�
56 orf56 L0010 85 DUF4942 domain-containing protein 100
57 orf57 L0011 80 hypothetical protein ESMG_02720 91.04
58 orf58 IS/328 transposase (Y. enterocolitica) 83 IS110-like element ISSfl8 family transposase 100 �
59 orf59 L0012 90 hypothetical protein G960_01162 98.72
1ORFs contained in the SRL pathogenicity island excluding orf1 (integrase), orf3 (rox), orf10-orf17/orf19-orf22 (antibiotic resistance genes), and orf26-orf33 (Ferric
Dicitrate Transport System), which have known protein products.
#Related proteins are from E. coli unless otherwise stated.
�Related to Multispecies proteins [Enterobacteriaceae] or [Gammaproteobacteria]
+Related to S. flexneri strain 2a
https://doi.org/10.1371/journal.pone.0228178.t002
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PAI strains (both S. flexneri 2a and S. sonnei), transformed with the orf8-orf9 region acquired
the phenotype associated to D-Asp metabolism (Fig 2B). Control experiments transforming S.
flexneri 1363 and S. sonnei 566 with pUC18G empty plasmid showed that this vector by itself
was not able to modify this phenotype (Fig 2B).
Racemization of D-aspartate requires orf8-orf9 region
We measured to what extent orf8-orf9 region (aspartate racemase and its putative transporter)
was involved in racemization of D- and L- form of aspartic acid. Minimal medium enriched
with 30 mM of D-Asp was incubated with wild type and mutant strains (108 CFU/mL) and the
racemization activity was measured via HPLC/MS-MS. As a control, minimal medium with
D-Asp 30 mM without bacteria was used. Results showed that the wild type strain S. flexneri
YSH6000 significantly metabolized the D-form compared to the control (Fig 3A). Also, we
found that the level of D-Asp decreased in the supernatant of the S. flexneri YSH6000 strain,
but also a moderate accumulation of the L- form was found as result of the racemization reac-
tion (Fig 3A). On the other hand, the S. flexneri 1363 strain was not able to metabolize D-Asp,
as concentration remained similar to the control medium (medium without bacteria) (Fig 3B).
S. flexneri 1363 complemented with the orf8-orf9 region (1363 pUC18G orf8-orf9), on the
Fig 2. orf8-orf9 region is responsible for metabolization of D-aspartic acid as a sole carbon source. Shigella flexneri and Shigella sonnei strains were cultured on
Shigella Minimal Medium supplemented with 0.01% w/v TTC as a redox indicator. (A) YSH6000 and its isogenic mutant for the SRL PAI, 1363 strain are shown. (B)
S. flexneri and S. sonnei SRL PAI-negative strains complemented with the orf8-orf9 region and their controls are shown. The graph shows the absorbance at 490 nm
of the bacterial cultures at 24 h (final absorbance minus initial absorbance). ANOVA and Tukey tests were performed, and significant results are represented by
asterisks (� = p<0.05). Error bars represent standard deviation.
https://doi.org/10.1371/journal.pone.0228178.g002
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Fig 3. Quantification of D- and L- form of aspartic acid in cultures supernatants using HPLC-MS/MS. Aspartic acid isomers were measured in
supernatants of cultures in minimal medium after 24 h of incubation at 37ºC for strains YSH6000 and its isogenic mutant, 1363 (A) and for S. flexneri and S.
sonnei SRL PAI-negative strains complemented with the orf8-orf9 region (B). ANOVA and Tukey tests were performed and significant results are
represented by asterisks (� = p<0.05). Error bars represent standard errors.
https://doi.org/10.1371/journal.pone.0228178.g003
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opposite, showed almost a total reduction of the D-form. The additional control, S. sonnei 566
strain complemented (566 pUC18G orf8-orf9) also showed a significant decrease of D-Asp and
a concomitant increase of the L- form due to racemization (Fig 3B). This result supports the
sufficiency of the region to produce the phenotype independently of the genetic background.
Growth in D-Asp as carbon source requires both orf8-orf9
In order to determine whether the metabolism of D-Asp was related to the individual activity
of the product of orf8 (racemase) or orf9 (transporter), each gene was cloned into the modified
pUC18G and used to transform S. flexneri 2a 1363. In parallel, an optimized minimal medium
with D-Asp to support growth in presence of 2 μg mL-1 gentamicin was generated and
YSH6000 transformed with the empty vector (YSH6000 pUC18G) was used as control. After
16 h of incubation at 37˚C, our results indicated that S. flexneri 2a 1363 complemented with
the orf8-orf9 region is able to grow in presence of D-Asp as sole carbon source, similarly to the
reference strain YSH6000 (Fig 4). However, the strains transformed with individual genes
(1363 pUC18G orf8 and 1363 pUC18G orf9) could not grow in presence of D-Asp. Indeed, the
data indicated that the OD of these strains and the 1363 pUC18G (SRL PAI negative)
decreased after 16 hours in comparison to the initial inoculum, which supports the toxic effect
of D-Asp in absence of the orf8-orf9 region (Fig 4).
Further, to analyze the growth dynamics of the strains in presence of D-Asp, growth curves
using optimized minimal medium with D-Asp or L-Asp (as comparison) were performed. Our
results indicated that all the strains are able to use L-Asp as sole carbon source (S2 Fig). However,
in presence of D-Asp as carbon source, only the strain positive for the SRL island (YSH6000
pUC18G) and the 1363 strain complemented with the orf8-orf9 region (1363 pUC18G orf8-orf9)
grew, similarly to what was observed in the overnight experiment (S2 Fig). These results support
the protective role of the orf8-orf9 from the SRL island against the toxicity of D-Asp and the rele-
vance of this region for the metabolism of this enantiomer as carbon source.
Discussion
S. flexneri is an enteropathogen globally isolated from different environments such as water,
soil and food [9–10]. In this context, the characterization of the ecology of Shigella in its natu-
ral niches is important to understand the life cycle outside the human body, its natural reser-
voir. In certain strains of S. flexneri, mobile genetic elements like pathogenicity islands are
responsible for the resistance to some toxic compounds found in the environment, such as
antibiotics [21]. SRL PAI of S. flexneri 2a YSH6000 carries 59 ORFs and the contribution of
these ORFs to the fitness and response to the environmental changes is still unknown. In this
work we have shown that the SRL PAI allows the metabolization of D-Asp via racemization. A
bioinformatics analysis identified the orf8 as an aspartate racemase, and orf9 as an anaerobic
C4-dicarboxylate membrane transporter protein, DcuA, possibly involved in the aspartic acid
translocation [22]. D-aspartic acid is widely available in the environment and it is a toxic com-
pound that acts as an inhibitor of the synthesis of proteins in bacteria [19, 20]. Indeed, Eisen-
stadt and coworkers described in 1959 that Pseudomonas saccharophila (Pelomonas
saccharophila) was unable to grow in presence of D-Asp when added to a minimal medium
enriched with maltose or cellobiose. The authors described that this phenomenon was only vis-
ible using some carbon sources and suggested that these variations could be associated to dif-
ferences in the levels of L-aspartate in the internal free amino acid pool of cells grown on the
different carbon sources. Similarly, the toxic effect of 0.01% D-Asp over bacterial growth could
be seen in our results in minimal medium with mannose as a carbon source and not in manni-
tol (the two carbon sources metabolized by these Shigella strains, according to Vitek results).
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However, the YSH6000 strain seems to be able to metabolize it. Our results of growing bacteria
in mannose and mannitol also agree with the work of Eisenstadt and coworkers about the
toxic effect of D-Asp dependent on the type of carbon source and internal L-aspartate pool. In
this context, recent works have explored the role of racemases and other enzymes in the meta-
bolization of D-amino acids. For example, racemic amino acids are present in the environment
and resident bacteria consume D- and L- enantiomers, either simultaneously or sequentially
depending on the level of their racemase activity [16]. Bacteria thus protect life on earth by
keeping D-amino acid free environment [16]. Similarly, amino acid malonylation in plants has
been proposed as a mechanism to detoxify these compounds [23]. Thus, it is possible to sug-
gest that the presence of the aspartate racemase in the SRL PAI, and therefore, the ability to
perform racemization of D-Asp would be beneficial to cope with the high concentrations of
D-amino acids in soil and plants. Indeed, our preliminary results indicated that S. flexneri 2a
YSH6000 is able to persist in significantly higher amounts in tomato pericarp in comparison
to the S. flexneri 2a 1363 (data not shown).
Fig 4. Bacterial growth in minimal medium with D-Asp as sole carbon source after 16 hours of incubation.
Absorbance at 600 nm was measured after overnight incubation (16 hours) at 37˚C in optimized minimal medium
with D-Asp and used to calculate final minus initial OD600. ANOVA test was performed, and significant results are
represented by asterisks (���� = p<0.0001). Error bars represent standard deviation.
https://doi.org/10.1371/journal.pone.0228178.g004
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Interestingly, it was recently described that bacterial D-amino acids and racemases have a
role in signaling in the human gut [24–25]. Similarly, another publication described the pres-
ence of 12 free D-amino acids (including D-Asp) in the intestine. According to the authors,
these molecules are produced mostly by bacteria belonging to the phylum Firmicutes and
could have a role in bacterial communication [26]. These findings lead us to wonder if this
aspartate racemase could be involved in the colonization of the human gastrointestinal tract.
Indeed, some racemases have been already linked to survival and pathogenesis, such as in the
case of an alanine racemase in Salmonella enterica serovar Enteritidis [27].
The ability to metabolize D-Asp as a carbon source has been previously described in envi-
ronmental strains [28, 29]. Protein similarity sequences analysis of the products of orf8-orf9
region from S. flexneri YSH6000 showed that it is also present as a functional unit in E. coli
strains such as E. coli HUSEC2011, E. coli O104:H4 str. 2009EL-2071 and E. coli O104:H4 str.
2011C-3493, suggesting that racemization of D-amino acids would occur in other pathogenic
organisms.
From the ecological point of view, pathogenicity islands such as SRL PAI are tools for hori-
zontal gene transfer [30] and by extension we speculate that these genes get a benefit by staying
within the island.
Conclusion
Our results indicate that both aspartate racemase and the transporter encoded by the orf8-orf9
region of the SRL PAI allows Shigella to metabolize D-Asp, conferring an advantage using this
D-amino acid as carbon source or detoxifying its toxic effect. The study of the common heri-
tance of these genes in enterobacteria and other bacterial strains is therefore important to
understand the relevance of this strategy for bacterial adaptation to the environment and
pathogenicity.
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